$GNFT:
1) great partner and will give a lot of money
2) research went smoothly
3) will be the best at the time of phase 3
$CBAY
1) problems with phase 2
2) possible problems with phase 3
3) most likely fda will require additional studies
https://t.co/JiqDb22cM0
@Nguyen I wrote before that there was a blocking of these stocks at a broker. The broker said he banned them because he considered them potentially dangerous. Only on application he allowed to sell the shares, but not to buy them. Today the blocking was lifted for buying
@benedetto_frank For the FDA the most important thing is safety and because there is no evidence in the long term they can turn it down for additional studies...
Key points in phase 3 mention that they plan to further prove long term safety, but will that satisfy the fda
@benedetto_frank I am more concerned about:
1) Why does the fda need it since previous studies have proven safety ?
2) will the company notify that they have given these documents ?
3) how long does it take the fda to analyze toxicity ?